[quote]Schwarzenegger wrote:
DrSkeptix wrote:
If the surgeon leaves a sensate nipple and areola, breast tissue remains.
The “total gland” is not removed.
(Surgery for male gynecomastia generally is not even a subcutaneous mastectomy.)
Sorry, fellas.
If I understand what you’re saying…
- If the nipple is still sensitive, there is still breast tissue.
- A subcutaneous mastectomy would result in total tissue removal, but this procedure is typically not done?
Well, a subcutaneous mastectomy is a method of removing breast tissue through an incision around the areola. This is opposed to other methods which either remove the areola, cut away excess skin (after removing breast tissue), and grafting the areola on to the remaining skin, and the method of completely removing everything and ending up with no areola (or breast tissue, of course).
I really don’t have any experience with this outside of reading a couple medical resources, but from my understanding there is breast tissue that is connected to the areola that cannon be removed without destroying the areola, which is one reason why many breast cancer patients undergoing subcutaneous mastectomy have recurring tumor growth post-surgery. This would lead me to believe that, provided you left the nipple in tact after gynecomastia surgery (which you obviously would), that there would be some bit of breast tissue left that could potentially experience future growth in response to estrogen. However, the amount left would be so small that this possibility would be extremely reduced, though not impossible.
The way I think about it (I don’t actually know how it works, though am willing to learn if anyone knows) is say you’ve got 10cc of breast tissue. That breast tissue will have a certain amount of estrogen receptors. Say you shrink it down to 2cc using Nolvadex or Arimidex, that 2cc still has the same amount of estrogen receptors, and thus allows for an easy return to “normal” size, and potentially expanded growth, in the presence of estrogen levels. If you were to actually remove the tissue and leave only .5-1cc post-surgery then you would actually reduce the number of estrogen receptors and subsequent growth potential, though with enough estrogen it would still be possible to experience continued breast tissue growth.
The reason I speculate it would work this way is that this is how adipose tissue works. If you lose weight, adipose tissue shrinks, but does not actually go away. Obviously this is a very simplistic example, but it is true for the huge majority of the population within normal fat loss scenario. If you gain weight the adipose tissue will expand until a certain size, at which point it will multiply. This is the reason obese individuals (not from birth) experience a lot of negative metabolic disorders, as adipose tissue releases certain hormones that regulate metabolism, hunger, etc.
Genetically predisposed obese individuals from birth vs. those who acquire it over time have a different makeup of adipose tissue and have different sensitivity to various hormones by by and from their adipose tissue. This makes me think that by actually eliminating the large majority of the breast tissue in those who have it (we’ll say those who are genetically predisposed to being more estrogen sensitive, at least I presume because I’ve had my gyno since puberty), the dynamics of growth and sensitivity to estrogen/etc. by the remaining breast tissue would mimic that of an individual not as sensitive to estrogen. While the potential for growth is still there, we may be able to cycle at 1000mg/wk with only very moderate AI/SERM supplementation, and perhaps none at 500mg/wk, as opposed to needing something even at 100-200mg/wk (which is at least how I am).
I think I got off track from my original idea, but at least I got out some good discussion. What do you guys think?[/quote]
Good post. I have nothing to add other than that intuitively this makes sense to me.